ECMO Setinde Heparin Nötralizasyonu

Öz

-

Anahtar Kelimeler

• -

Neutralization of Heparin for Extracorporeal Membrane Oxygenation

Öz

-

Anahtar Kelimeler

• -

Kaynakça

1. Firmin RK, Killer HM. Extracorporeal membrane oxygenation. Perfusion 1999;14:291-7.
2. Rais-Bahrami K, Short BL. The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 2000;24:406-17.
3. Lustbader D, Fein A. Other modalities of oxygen therapy. Respir Care Clin N Am 2000;6:659-74.
4. Peek GJ, Sosnowski AW. Extracorporeal membrane oxygenation for paediatric respiratory failure. Bri Med Bull 1997;53:745-56.
5. Beghetti M, Rimersberger PC. Mechanical circulatory support in pediatric patients. Intensive Care Med 2000;26: 350-2.
6. Dickey LA, Butler TJ, Bergmann TM, Bates ME, Null DM. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in short-term pig model. Perfusion 1994;9:327-33.
7. Segesser LK. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 1996;61:330-5.
8. Ray MJ, Hales MM, Brown L, O’Brien MF, Stafford EG. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. Ann Thorac Surg 2001;72:521-6.

9. Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 1999;45:250-63.
10. Yang VC, Port FK, Kim JS, Teng CL, Till GO, Wakefield TW. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-97.
11. Boigner H, Lechner E, Brock H, Golej J, Trittenwein G. Life threatening cardiopulmonary failure following protamine reversal of heparin after cardiopulmonary bypass. Paediatr Anaesth 2001;11:729-32.
12. Malviya S. Monitoring and management of anticoagulation in children requiring extracorporeal circulation. Semin Thromb Hemost 1997;23:563-7.
13. Mikhailidis DP. Regarding ‘heparin modulates integrin function in human platelets’. J Vasc Surg 2002;35:405-6.
14. Greenbaum RA, Barradas MA, Mikhailidis DR, Jeremy JY, Evans TR, Dandona P. Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res 1987;21:878-85.
15. Sugimoto M, Miyata S. Functional property of von Willebrand factor under flowing blood. Int J Hematol 2002;75:19-24.